-
Je něco špatně v tomto záznamu ?
Rational Design of Self-Emulsifying Pellet Formulation of Thymol: Technology Development Guided by Molecular-Level Structure Characterization and Ex Vivo Testing
J. Macku, K. Kubova, M. Urbanova, J. Muselik, A. Franc, G. Koutna, M. Pavelkova, D. Vetchy, J. Masek, E. Maskova, J. Brus
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
GA22-03187S
Czech Science Foundation
MUNI/A/1251/2021
Masaryk University
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
- Publikační typ
- časopisecké články MeSH
The growing need for processing natural lipophilic and often volatile substances such as thymol, a promising candidate for topical treatment of intestinal mucosa, led us to the utilization of solid-state nuclear magnetic resonance (ss-NMR) spectroscopy for the rational design of enteric pellets with a thymol self-emulsifying system (SES). The SES (triacylglycerol, Labrasol®, and propylene glycol) provided a stable o/w emulsion with particle size between 1 and 7 μm. The ex vivo experiment confirmed the SES mucosal permeation and thymol delivery to enterocytes. Pellets W90 (MCC, Neusilin®US2, chitosan) were prepared using distilled water (90 g) by the M1-M3 extrusion/spheronisation methods varying in steps number and/or cumulative time. The pellets (705-740 μm) showed mostly comparable properties-zero friability, low intraparticular porosity (0-0.71%), and relatively high density (1.43-1.45%). They exhibited similar thymol release for 6 h (burst effect in 15th min ca. 60%), but its content increased (30-39.6 mg/g) with a shorter process time. The M3-W90 fluid-bed coated pellets (Eudragit®L) prevented undesirable thymol release in stomach conditions (<10% for 3 h). A detailed, ss-NMR investigation revealed structural differences across samples prepared by M1-M3 methods concerning system stability and internal interactions. The suggested formulation and methodology are promising for other lipophilic volatiles in treating intestinal diseases.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22023671
- 003
- CZ-PrNML
- 005
- 20221031095122.0
- 007
- ta
- 008
- 221010s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/pharmaceutics14081545 $2 doi
- 035 __
- $a (PubMed)35893801
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Macku, Jan $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, 612 00 Brno, Czech Republic $u Department of NMR Spectroscopy, Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
- 245 10
- $a Rational Design of Self-Emulsifying Pellet Formulation of Thymol: Technology Development Guided by Molecular-Level Structure Characterization and Ex Vivo Testing / $c J. Macku, K. Kubova, M. Urbanova, J. Muselik, A. Franc, G. Koutna, M. Pavelkova, D. Vetchy, J. Masek, E. Maskova, J. Brus
- 520 9_
- $a The growing need for processing natural lipophilic and often volatile substances such as thymol, a promising candidate for topical treatment of intestinal mucosa, led us to the utilization of solid-state nuclear magnetic resonance (ss-NMR) spectroscopy for the rational design of enteric pellets with a thymol self-emulsifying system (SES). The SES (triacylglycerol, Labrasol®, and propylene glycol) provided a stable o/w emulsion with particle size between 1 and 7 μm. The ex vivo experiment confirmed the SES mucosal permeation and thymol delivery to enterocytes. Pellets W90 (MCC, Neusilin®US2, chitosan) were prepared using distilled water (90 g) by the M1-M3 extrusion/spheronisation methods varying in steps number and/or cumulative time. The pellets (705-740 μm) showed mostly comparable properties-zero friability, low intraparticular porosity (0-0.71%), and relatively high density (1.43-1.45%). They exhibited similar thymol release for 6 h (burst effect in 15th min ca. 60%), but its content increased (30-39.6 mg/g) with a shorter process time. The M3-W90 fluid-bed coated pellets (Eudragit®L) prevented undesirable thymol release in stomach conditions (<10% for 3 h). A detailed, ss-NMR investigation revealed structural differences across samples prepared by M1-M3 methods concerning system stability and internal interactions. The suggested formulation and methodology are promising for other lipophilic volatiles in treating intestinal diseases.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kubova, Katerina $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, 612 00 Brno, Czech Republic $1 0000000249702084
- 700 1_
- $a Urbanova, Martina $u Department of NMR Spectroscopy, Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
- 700 1_
- $a Muselik, Jan $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, 612 00 Brno, Czech Republic
- 700 1_
- $a Franc, Ales $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, 612 00 Brno, Czech Republic $1 0000000220274717
- 700 1_
- $a Koutna, Gabriela $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, 612 00 Brno, Czech Republic
- 700 1_
- $a Pavelkova, Miroslava $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, 612 00 Brno, Czech Republic
- 700 1_
- $a Vetchy, David $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, 612 00 Brno, Czech Republic
- 700 1_
- $a Masek, Josef $u Department of Pharmacology and Toxicology, Veterinary Research Institute, 621 00 Brno, Czech Republic $1 0000000167888487
- 700 1_
- $a Maskova, Eliska $u Department of Pharmacology and Toxicology, Veterinary Research Institute, 621 00 Brno, Czech Republic
- 700 1_
- $a Brus, Jiri $u Department of NMR Spectroscopy, Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic $1 000000032692612X
- 773 0_
- $w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 14, č. 8 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35893801 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20221010 $b ABA008
- 991 __
- $a 20221031095120 $b ABA008
- 999 __
- $a ind $b bmc $g 1853968 $s 1174959
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 14 $c 8 $e 20220725 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
- GRA __
- $a GA22-03187S $p Czech Science Foundation
- GRA __
- $a MUNI/A/1251/2021 $p Masaryk University
- LZP __
- $a Pubmed-20221010